Critical Care & Emergency Medicine Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
This prospective randomized trial compared the sedative efficacy of dexmedetomidine versus midazolam in children undergoing scoliosis surgery. The study provides evidence that compared to midazolam, dexmedetomidine decreased opioid consumption, Numeric Visual Analog Scale (NVAS) scores...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
2 Recommendations, most recent by
Past 7 Days
New Articles Recommended
Past 30 Days
30Articles Classified As Good for Teaching322 total
11Articles Classified As Review / Commentary421 total
23Articles Classified As Controversial1,045 total
7Articles Classified As Technical Advance433 total
21Articles Classified As Confirmation2,572 total
4Articles Classified As Novel Drug Target34 total
2Articles Classified As Refutation210 total
52Articles Classified As Clinical Trial3,031 total
2Articles Classified As Changes Clinical Practice546 total
11Articles Classified As Interesting Hypothesis1,116 total
31Articles Classified As New Finding2,561 total
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.